---
title: "Tenax Therapeutics discloses ADAR1 Capital Management as beneficial owner in Form 3 filing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296832135.md"
description: "Tenax Therapeutics filed Form 3 disclosing ADAR1 Capital Management as a beneficial owner holding 10% of common stock (3,827,951 shares). The filing also details holdings of 59,073 pre-funded warrants exercisable at $0.01 and 31,096 warrants exercisable at $4.50. The ownership event occurred on August 20, 2026, with the filing signed on August 24, 2026."
datetime: "2026-08-24T21:51:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296832135.md)
  - [en](https://longbridge.com/en/news/296832135.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296832135.md)
generator: "portal-rs"
---

# Tenax Therapeutics discloses ADAR1 Capital Management as beneficial owner in Form 3 filing

-   Tenax Therapeutics Form 3 disclosed ADAR1 Capital Management as a 10% owner, reporting 3,827,951 shares of common stock. \* Holdings also included 59,073 pre-funded warrants exercisable at USD 0.01 per share. \* Filing listed 31,096 warrants exercisable at USD 4.5 per share. \* Ownership event date was Aug. 20, 2026; the filing was signed Aug. 24, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenax Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001940272-26-000016), on August 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [TENX.US](https://longbridge.com/en/quote/TENX.US.md)

## Related News & Research

- [Tenax Therapeutics CEO to present at Cantor Global Healthcare Conference](https://longbridge.com/en/news/297640837.md)
- [Tenax presents Phase 3 LEVEL data showing TNX-103 boosts 6-minute walk distance in lower baseline subgroup](https://longbridge.com/en/news/297402619.md)
- [Aethlon Medical says all pre-funded warrants are exercised](https://longbridge.com/en/news/297523583.md)
- [Zoomcar completes warrant exchange, to issue 317,683,180 shares](https://longbridge.com/en/news/297555986.md)
- [eWork Group held extraordinary shareholders meeting on incentive programs](https://longbridge.com/en/news/297764391.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**